AnheuserBusch Inbev BUD Q1 2026 Earnings EPS Beats Estimates by 815 Amid Volume Recovery Evercore Q1 2026 Earnings Blowout EPS Beats Estimates by 4665 CBRE Q1 2026 Earnings Stellar EPS Beat Underscores Resilient Business Model OCS Q1 2026 Earnings WiderthanExpected Losses Amid Continued Pipeline Investment MBIA Inc MBI Q1 2026 Earnings Severe EPS Miss Triggers Stock Decline JUNS Q4 2025 Earnings Narrower Loss Surprises Yet Stock Falls on PreRevenue Path KNSL Q1 2026 Earnings EPS Surges Past Estimates on Strong Underwriting Performance BOBS Q1 2026 Earnings Earnings Beat Estimates Amid Challenging Retail Environment Lisata Therapeutics LSTA Q3 2025 Earnings EPS Beat Drives Positive Stock Reaction MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline Hour Loop Inc HOUR Q4 2024 Earnings Narrowing Losses in a Challenging Retail Environment Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage